News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

This program is initiated, funded, and developed by Biogen.

Advertisement

Articles by This program is initiated, funded, and developed by Biogen.

Selecting the Right Patients for Anti-VEGF Biosimilar Therapy

ByThis program is initiated, funded, and developed by Biogen.
April 18th 2024

Impact of Biosimilars on the Healthcare System

ByThis program is initiated, funded, and developed by Biogen.
April 18th 2024

Key Clinical Findings on the Efficacy, Safety Profile and Immunogenicity of Biosimilar SB11

ByThis program is initiated, funded, and developed by Biogen.
April 18th 2024

Review of the Phase III Clinical Trial for Biosimilar SB11

ByThis program is initiated, funded, and developed by Biogen.
April 18th 2024

Biosimilar Approval Process by Regulatory Bodies

ByThis program is initiated, funded, and developed by Biogen.
April 18th 2024

Overview of Biosimilars

ByThis program is initiated, funded, and developed by Biogen.
April 18th 2024

Need for Awareness About Biosimilars

ByThis program is initiated, funded, and developed by Biogen.
April 18th 2024
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Modern Retina

    1

    Navigating geographic atrophy from biomarkers to bilateral therapy

    2

    Eichenbaum Acorns: Mentorship, momentum, and the making of a retina podcast

    3

    Long-lived Greenland sharks may point to new approaches for retinal disease

    4

    Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab

    • About
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us